Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for the prevention of delirium in ICU patients undergoing elective cardiac surgery (INSPIRE)
2025-524680-21-00Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Intranasal human insulin with Placebo (intranasal 0.9% sodium chloride) (2 arms). Primary endpoints: Feasibility metrics, Tolerability metrics and 1 more. Started Mar 2026; status: completed.
02
Drugs
human insulin
03
Conditions
delirium
Beyond the preview
Go deeper on 2025-524680-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524680-21-00.